No Data
Organogenesis Holdings Inc. (ORGO): Is It Among the Best NASDAQ Penny Stocks to Invest In Now?
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?
Is Organogenesis a Hidden Gem in the Biotech Sector?
Lake Street Initiates Organogenesis(ORGO.US) With Buy Rating, Announces Target Price $5
Lake Street analyst Brooks O'Neil initiates coverage on $Organogenesis(ORGO.US)$ with a buy rating, and sets the target price at $5.According to TipRanks data, the analyst has a success rate of 43.3%
Organogenesis Holdings Initiated at Buy by Lake Street
Organogenesis Holdings Initiated at Buy by Lake Street